Tann Cally J, Webb Emily L, Lassman Rachel, Ssekyewa Julius, Sewegaba Margaret, Musoke Margaret, Burgoine Kathy, Hagmann Cornelia, Deane-Bowers Eleanor, Norman Kerstin, Milln Jack, Kurinczuk Jennifer J, Elliott Alison M, Martinez-Biarge Miriam, Nakakeeto Margaret, Robertson Nicola J, Cowan Frances M
Department of Infectious Disease Epidemiology, School of Hygiene and Tropical Medicine, London, UK.
Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
EClinicalMedicine. 2018 Dec;6:26-35. doi: 10.1016/j.eclinm.2018.12.001.
Neonatal encephalopathy (NE) is a leading cause of global child mortality. Survivor outcomes in low-resource settings are poorly described. We present early childhood outcomes after NE in Uganda.
We conducted a prospective cohort study of term-born infants with NE (n = 210) and a comparison group of term non-encephalopathic (non-NE) infants (n = 409), assessing neurodevelopmental impairment (NDI) and growth at 27-30 months. Relationships between early clinical parameters and later outcomes were summarised using risk ratios (RR).
Mortality by 27-30 months was 40·3% after NE and 3·8% in non-NE infants. Impairment-free survival occurred in 41·6% after NE and 98·7% of non-NE infants. Amongst NE survivors, 29·3% had NDI including 19·0% with cerebral palsy (CP), commonly bilateral spastic CP (64%); 10·3% had global developmental delay (GDD) without CP. CP was frequently associated with childhood seizures, vision and hearing loss and mortality. NDI was commonly associated with undernutrition (44·1% Z-score < - 2) and microcephaly (32·4% Z-score < - 2). Motor function scores were reduced in NE survivors without CP/GDD compared to non-NE infants (median difference - 8·2 (95% confidence interval; - 13·0, - 3·7)). Neonatal clinical seizures (RR 4.1(2.0-8.7)), abnormalities on cranial ultrasound, (RR 7.0(3.8-16.3), nasogastric feeding at discharge (RR 3·6(2·1-6·1)), and small head circumference at one year (Z-score < - 2, RR 4·9(2·9-5·6)) increased the risk of NDI.
In this sub-Saharan African population, death and neurodevelopmental disability after NE were common. CP was associated with sensorineural impairment, malnutrition, seizures and high mortality by 2 years. Early clinical parameters predicted impairment outcomes.
新生儿脑病(NE)是全球儿童死亡的主要原因。资源匮乏地区幸存者的结局描述较少。我们展示了乌干达新生儿脑病后的幼儿结局。
我们对足月出生的新生儿脑病患儿(n = 210)和足月非脑病(非NE)婴儿对照组(n = 409)进行了一项前瞻性队列研究,评估27至30个月时的神经发育障碍(NDI)和生长情况。使用风险比(RR)总结早期临床参数与后期结局之间的关系。
27至30个月时,新生儿脑病组的死亡率为40.3%,非NE婴儿组为3.8%。新生儿脑病组41.6%的患儿无损伤存活,非NE婴儿组为98.7%。在新生儿脑病幸存者中,29.3%有神经发育障碍,其中19.0%患有脑瘫(CP),常见双侧痉挛性脑瘫(64%);10.3%有全面发育迟缓(GDD)但无脑瘫。脑瘫常与儿童期癫痫、视力和听力丧失及死亡相关。神经发育障碍常与营养不良(44.1% Z评分< -2)和小头畸形(32.4% Z评分< -2)相关。与非NE婴儿相比,无脑瘫/全面发育迟缓的新生儿脑病幸存者的运动功能评分降低(中位数差异 -8.2(95%置信区间;-13.0,-3.7))。新生儿临床癫痫(RR 4.1(2.0 - 8.7))、头颅超声异常(RR 7.0(3.8 - 16.3))、出院时鼻饲喂养(RR 3.6(2.1 - 6.1))以及1岁时头围小(Z评分< -2,RR 4.9(2.9 - 5.6))增加了神经发育障碍的风险。
在这个撒哈拉以南非洲人群中,新生儿脑病后的死亡和神经发育残疾很常见。脑瘫与感觉神经性损伤、营养不良、癫痫和2岁时的高死亡率相关。早期临床参数可预测损伤结局。